Investment ThemesDetailed Quotes
Gene Editing Watchlist

Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.

  • 1425.490
  • +6.100+0.43%
Close 02/23 16:00 ET
1436.937High1421.806Low
Constituent Stocks: 10Top Rising: BLUE+5.93%
Intraday
  • 5D
  • 1D
  • 1W
  • 1M
  • 1Q
  • 1Y
Constituent Stocks
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
BLUEbluebird bio
1.2500.070+5.93%11.45M14.44M1.2201.1801.3201.171240.93M239.78M192.74M191.82M+15.74%+19.05%+11.61%-67.45%-66.84%-75.59%-9.42%--5.97%LossLoss12.60%Biotechnology
SGMOSangamo Therapeutics
1.1300.030+2.73%2.33M2.61M1.1501.1001.2101.050200.40M182.74M177.35M161.72M+7.62%+105.45%+149.83%+202.54%+16.58%-57.44%+107.99%--1.44%LossLoss14.55%Biotechnology
BEAMBeam Therapeutics
33.9900.450+1.34%1.01M34.36M33.36033.54034.66033.2752.77B2.40B81.50M70.69M+2.94%+20.92%+36.40%+16.56%+46.64%-12.67%+24.87%--1.43%LossLoss4.13%Biotechnology
APLSApellis Pharmaceuticals
68.4700.880+1.30%771.23K52.53M67.49067.59068.73067.0208.11B5.40B118.50M78.91M+1.32%+0.51%+3.35%+41.79%+62.21%+2.67%+14.38%--0.98%LossLoss2.53%Biotechnology
VRTXVertex Pharmaceuticals
430.1103.330+0.78%749.86K323.27M430.000426.780434.500429.070111.10B110.68B258.31M257.33M+0.90%+1.67%+0.03%+22.82%+23.47%+49.67%+5.71%--0.29%30.9730.971.27%Biotechnology
CRBUCaribou Biosciences
6.9400.020+0.29%724.58K5.00M6.9106.9206.9806.800613.71M456.60M88.43M65.79M-0.86%+2.21%+29.24%+20.70%+17.83%+19.66%+21.12%--1.10%LossLoss2.60%Biotechnology
AAgilent Technologies
132.0300.010+0.01%1.88M248.66M132.800132.020133.360131.57038.69B38.54B293.04M291.91M-2.02%-1.52%+1.66%+5.79%+9.46%-5.81%-5.03%0.68%0.64%31.5131.511.36%Diagnostics & Research
EDITEditas Medicine
7.810-0.120-1.51%1.05M8.13M7.8907.9307.9207.675637.87M593.15M81.67M75.95M-6.02%+8.93%+0.39%-26.70%-12.35%-13.80%-22.90%--1.38%LossLoss3.09%Biotechnology
CRSPCRISPR Therapeutics
83.990-2.200-2.55%2.05M172.46M85.93086.19087.69082.3506.74B6.65B80.28M79.21M-0.58%+22.03%+33.59%+17.29%+67.95%+74.91%+34.17%--2.59%LossLoss6.20%Biotechnology
NTLAIntellia Therapeutics
26.100-1.080-3.97%2.11M54.72M26.72027.18027.03025.4902.51B2.30B96.11M88.28M-8.32%-4.99%+4.03%-14.85%-30.36%-30.84%-14.40%--2.39%LossLoss5.67%Biotechnology